Mitoxantrone (mitoxantrone): Reviews and patient testimonials
Back to the list of medications
Medication indications
Mitoxantrone (Mitozantrone) 2 mg/ml Sterile Concentrate
Mitoxantrone is indicated in the treatment of metastatic breast cancer, non-Hodgkin's lymphoma and adult acute non-lymphocytic leukaemia. Mitoxantrone has also been used in the palliation of non-resectable primary hepatocellular carcinoma.Mitoxantrone 2 mg/ml concentrate for solution for infusion
Mitoxantrone 2 mg/ml solution is indicated in the treatment of metastatic breast cancer.
Mitoxantrone 2 mg/ml solution is indicated in the treatment of non-Hodgkin's lymphoma.
Mitoxantrone 2 mg/ml solution is indicated for the treatment and acute myeloid leukaemia (AML) in adults.
Mitoxantrone 2 mg/ml solution in combination regimens is indicated in the remission-induction treatment of blast crisis in chronic myeloid leukaemia.
Mitoxantrone 2 mg/ml solution is indicated in combination with corticosteroids for palliation (e.g. pain relief) related to advanced castrate resistant prostate cancer.
Mitoxantrone 2 mg/ml solution is indicated for treatment of patients with highly active relapsing multiple sclerosis associated with rapidly evolving disability where no alternative therapeutic options exist (see sections 4.2, 4.4 and 5.1).
Route of administration: Injectable
Molecule: mitoxantrone
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.